The World Health Organisation is calling for a massive investment by the rich governments of the world into the health of the world’s poor. This is the conclusion of a report by the Commission on Macroeconomics and Health (CMH, 2001a), launched in London on 20.12.01. The report calls for an increased investment in health of US$27 billion per year by the year 2007. It is estimated that such an investment would save 8 million lives per year. Speaking at the launch, Jeffrey Sachs, the Commission’s chair reported that the new Global Fund for AIDS, TB and malaria (see IPHN bulletin 8 http://www.iphn.org/bulletin8.html) could be one of several vehicles for delivering such funds, delivering perhaps up to 30% of the total fund needed. He said, “We need to bankrupt the Global Fund as soon as possible to demonstrate that poor countries have the absorptive capacity and to force the US government to act.” This argument has strong similarities with calls from the United Nations Development Programme [UNDP] for health to be considered a ‘global public good’ (Kaul et al., 1999). The Commission itself refers to global public goods and defines them as ‘goods whose characteristics of publicness (nonrivalry in consumption and nonexcludability of benefits) extend to more than one set of countries or more than one geographic regions (CMH, 2001a, p.190).’ One of the six working groups was specifically focused on the subject of global public goods for health (CMH, 2001a, p.151 – see http://www.cmhealth.org/wg2.htm). A particularly strong emphasis in the commission’s report was on the status of health knowledge and information as a global public good (CMH, 2001a, pp.76-86).
What are Public Goods?
The concept of dividing goods into ‘public’ and ‘private’ goods arises from classical economics and can be dated back to the 18th century. According to this concept, characteristics of public goods include:
· Non-rivalry in consumption which means that one person’s use of a good does not prevent another person from using it (Kaul et al, 1999). This is termed by some as non-divisibility (Chen et al, 1999)
· Non-excludability, i.e. use of item is available to all people/groups of people (Kaul et al, 1999)
· Non-rejectability, individuals are unable to choose to forego consumption (Preker et al, 2000)
An example of a private good might be a piece of cake. If I eat it, no-one else can (i.e. it is rival). I may chose to share it with my friends, excluding others (i.e. excludable). I may choose not to eat cake (i.e. it is rejectable). On the other hand, traffic lights might be considered an example of a public good. My use of a traffic light does not prevent others from using it (i.e. it is non-rival). Traffic lights apply to all people (i.e. it is non-excludable) and it would be almost impossible to not use traffic lights (i.e. it is non-rejectable). Other examples of public goods might include peace, law and order and good macroeconomic management. However, this distinction between private and public goods is not always that clear cut. Although some goods might be purely private or purely public, there will be some that are mixed/impure. Goods which are non-rival amongst a certain group of people can be termed ‘club goods’ and those which are available to all but are rival can be termed ‘common pool resources’ (see figure 1). These ‘impure’ goods are more common than the pure type. Consequently, the term public good is often used to include both pure and impure public goods (i.e. the shaded area in figure 1 ) (Kaul et al, 1999). Commonly, five sectors of public goods can be identified, namely environment, health, governance, security and knowledge (Te Velde, 2002).
According to neo-classical economic theory, attempting to provide pure public goods through competitive markets will lead to sub-optimal quality, quantity and price (Preker et al, 2000). Two reasons for this can be identified for this. First, individuals motivated by self-interest only will tend to ‘free ride’ concerning the provision of these goods. Secondly, individuals will tend to make sub-optimal decisions on these issues if those decisions are made in isolation from others. Effective provision of public goods requires co-operation and measures which promote communication and build trust (Kaul et al, 1999). What are Global Goods?
In many cases, it is assumed that responsibility for provision of public goods rests with the nation state. However, there may be some cases where goods are global rather than national. Suggested criteria for deciding this include the requirement that global goods are quasi-universal in terms of:
· Countries, that is they involve more than one group · People, that is they involve several/all population groups, e.g. socio-economic groups, ethnic groups, gender, religion etc.
· Generations, that is they affect current and future generations In order to assess what kind of goods might be global in this regard, it may be useful to consider problems (i.e. global ‘bads’) which fulfil those criteria, for example banking crises, Internet crime and fraud, Ill-health due to increased trade and travel, drug abuse, smoking etc. (Kaul et al, 1999). Global public goods may be considered of two types. There are final global public goods which consist of desired outcomes and may be tangible, e.g. the environment or intangible, e.g. peace. For example, the World Bank recognizes five global public goods priorities, namely communicable diseases, environmental commons, information & knowledge, trade & integration and international financial architecture (World Bank, 2001). Secondly, there are intermediate global public goods which consist of international regimes, agreements and institutions which have the aim of delivering final global public goods. Examples might include frameworks for international transport and communication, health, the environment, demographics, judicial systems, human rights and macroeconomic policy (Kaul et al, 1999).
Is an Economics-based Definition of Global Public Goods Adequate?
So far, this paper has considered the concept of global public goods from the perspective of neo-classical economics. However, the validity of defining global public goods in this way has been challenged by some people. For example, Wolfgang Reinicke, Director of the Global Public Policy Project, an economist with long experience of working in the World Bank, said, “In most societies, the spectrum of public goods goes far beyond what a classic economic definition of joint consumption and non-excludability would capture. It is far more important for the members of each society to determine - in a transparent, democratic process - what is and what is not in the public interest (Reinicke, 2001).” Supplying Global Public Goods As seen earlier, classical economic theory predicts that competitive markets will provide public goods in a sub-optimal way. This leads to the problem of how public goods, in general and global public goods, in particular can be supplied. Two key factors have been identified in determining how sub-optimal provision through markets will be. These factors are the ‘degree of publicness’ of the goods and the number of beneficiaries. The latter factor is a particular problem for global public goods whose beneficiaries number billions and who are represented by more than 180 nation states. These states have their own self-interests and there are a diverse range of interest groups within the world’s population (Kaul et al, 1999). There is therefore a strong argument for international aid to be used to finance global public goods. Three building blocks for this argument are that:
· The private sector will not provide a sufficient amount of public goods · Individual countries have insufficient incentives to make an optimal contribution to global public goods because benefits do not accrue equally nationally · Poor countries lack the resources to make a full contribution to global public goods (Te Velde, 2002)
Increasingly, the World Bank is seen as a financing mechanism through which global public goods can be provided. The Global Environment Fund would be one such example and it has been proposed that the Global Fund for AIDS, TB and Malaria be administered in a similar way (Unknown, 2002). Global public policy networks are also seen as having an important role in the area of supply of global public goods because they bring together diverse interest groups and can address transnational issues which no single group can address alone. Examples include:
· Placing issues on the global agenda, e.g. landmines, Jubilee 2000 · Facilitating setting of global standards, e.g. World Commission on Dams · Developing mechanisms for producing/sharing critical knowledge, e.g. Consultative Group on International Agricultural Research [CGIAR] · Creating markets where they are lacking, e.g. GAVI · Developing mechanisms for innovative implementation , e.g. Global Environment Facility · Creating trust and promote participation - reducing democratic deficit – an example of what happens when this fails would be the demonstrations in Seattle and against the workings of the World Bank (Reinicke, 2001).
Is health a global public good?
Traditionally, diseases can be divided into three groups, communicable diseases, communicable diseases and injuries. Because treatment of infectious diseases produces benefits to people other than those treated (termed positive externalities by economists), the control of communicable diseases has been widely considered a public good. However, because most of the determinants of non-communicable disease appear to be individual lifestyle choices, e.g. diet, tobacco use, exercise etc. treatment of these diseases is widely seen as a private good (Chen et al, 1999). However, applying strict classical economic criteria to health goods would result in very few being considered ‘pure public goods’ because most have some degree of excludability, rivalry and rejectability. For example, a vaccine given to one person is not available for another and people may choose not to be vaccinated (Preker etal, 2000).
However, even if health is accepted as a public good, much of it is likely to be seen as a national public good rather than one with global implications. For example, Te Velde considers primary health care as a national public good and only the prevention of disease spread across borders as a global public good (Te Velde, 2002). However, others have argued that health has become much more of a global public good because of a number of influences of globalization. First, increased international linkages through trade, migration and information flows not only provide opportunity for cross-border transmission of infectious agents but also allow ‘transmission’ of behavioural and environmental risks. Secondly, increased pressure on common-pool global resources, e.g. air and water, brings its own threats (Chen et al, 1999). Examples of health effects which can be considered global public goods as a result of globalization might include:
· Health effects of environmental change, e.g. global warming, ozone depletion, toxic waste disposal · Tobacco usage – this is not only influenced by individual behaviour but by global marketing campaigns · Illicit drug use – globalization has made control of drug trafficking more difficult (Chen et al, 1999)
However, all these issues are based on the same logic as focusing on the cross-border transmission of infectious disease as a global public good, namely that the causes and effects of disease, particularly in an era of globalization, are not limited to national boundaries and need to be approached on a global level. Another logic for considering health as a global public good can be considered in terms of the global imperative for poverty reduction (Te Velde, 2002). This is being used by a number of politicians as a basis for investment in health and development, for example Gordon Brown, the UK’s Finance Minister. The basis of this argument is that investment in health is a key element of an effective poverty reduction strategy and reducing poverty in poorer countries is essential if conflict is to be reduced, communicable disease controlled and environmental damage minimized. In a presentation to the UK Health and Development Forum in London in February 2002, a WHO economist distinguished between ‘health as a global public good’ and ‘global public goods for health’. For an area of health to be considered a global public good he explained that efforts to promote it would need to produce global health and economic benefits. On this basis, control of communicable disease, e.g. polio eradication is widely considered a global public good. On the other hand, there are many global public goods for health, that is global public goods which have health effects. Examples would include medical technologies, tobacco control and trade agreements. He also stressed the importance of ‘access goods’ – those goods which allow a person to benefit from a global public good. For example, a radio allows a person access to the radio waves which can be considered a global public good. He argued for health systems to be considered an access good in relation to many of the technological advances in health which could be considered global public goods (Woodward, 2002).
Conclusions It seems uncontroversial that certain aspects of health can be considered a global public good, particularly the control of infectious diseases which can spread across national borders. However, in an increasingly globalised world, it can be argued that, more and more, the cause and effects of disease are transnational. Finally, it can be argued that all of health should be considered a global public good because it is a key component of another global public good, poverty reduction, and because the global community has determined that it should so be considered. The report of the Commission on Macroeconomics and Health is not always explicit about the way it is interpreting health as a global public good. The main argument of the report is that rich countries should invest in the health of poorer countries as a way of supporting economic development and contributing to poverty alleviation. This is presumably of value to the international community and could therefore be considered a global public good. Some of this thinking is seen in statements associated with the commission which claim that controlling the diseases of the poor will promote political and social stability (CMH, 2001b). This is also seen in some of the quotes attributed to the Commissioners. For example, Manmohan Singh, a former Indian Finance Minister said, “We have an historical opportunity to combine and use resources and know-how to ensure better health and greater economic growth in just a couple of decades. If we want equity and security in our lifetime and for future generations, we cannot afford to miss this opportunity.” Takatoshi Kato of the Bank of Tokyo-Mitsubishi said, “We must begin to see development assistance more in terms of an investment in the future – in the protection of the global well-being, including peace, healthy populations, a healthy environment and a more equitable economic system (CMH, 2001c).” These statements clearly see investment in the health of poor people as contributing to a wide range of global public goods including equity, security, peace and a healthy environment. However, when the report refers explicitly to global public goods, it does so in a much more limited way, for example to refer to the work of global institutions (p.13) and the importance of health information and knowledge (pp.76-86) (CMH, 2001a).
UNDP is perhaps the lead agency in trying to promote a broadening of the concept of public goods to embrace all aspects of health, presumably in an attempt to encourage rich governments to provide additional non-aid funds for global health based on self-interest arguments. However, many NGOs have reservations about this approach. These reservations include:
· Concerns about pursuing arguments based on classical economic models · Fear of marginalizing more basic concepts such as equity and health as a human right · Fear of promoting inappropriate solutions, e.g. more stringent immigration controls as a way of controlling infectious disease · Fear of promoting vertical programmes · Risk of promoting northern agendas and further marginalizing country priorities · The confusing nature of the concepts and terms (Keith, 2002)
Discussion questions Is the concept of global public goods useful to us? How do we wish to define this? Do we see health as a global public good? On what basis do we come to that conclusion? Does this cover all aspects of health or just certain parts?
1. Editorial
2. Equity in Health
The XIV International AIDS Conference (Barcelona, Spain, July 2002) has received almost 10 500 abstract submissions from the world’s leading scientists, clinicians, community representatives and people living with HIV/AIDS. This is the highest number of submissions ever received in the history of the series of international AIDS conferences.
Inadequate drinking water and sanitation, indoor air pollution, and accidents, injuries and poisonings, are a few of the causes of the 3 million deaths per year of children under five due to environmental hazards. WHO is addressing environmental hazards which specifically affect children at the International Conference on Environmental Threats to the Health of Children. This opens today in Bangkok. WHO is also monitoring these issues through the Task Force for the Protection of Children’s Environmental Health.
The Global Fund to Fight AIDS, Tuberculosis and Malaria, a new initiative to combat the epidemics that kill six million people each year, today [11 March] announced the appointment of an international panel of experts that will review all grant proposals and make recommendations to the Board for funding.
According to the UN agency coordinating the HIV/AIDS epidemic (UNAIDS) at least 28.1 million Africans are living with the disease. Since the beginning of the epidemic in early 1980's, more than 19 million Africans have perished from AIDS. Largely due to AIDS, the average life expectancy in Sub-Sahara Africa is only 47 years instead of 62 years, if the disease were not a factor. Without any doubt, HIV/AIDS is a serious threat to the future well being of the continent. The specter of 14 million AIDS orphans, and counting, complicates an already dicey situation.
A rebellion against government policy on the treatment of HIV/AIDS is taking place in South Africa, with four provinical governments openly defying national policy and announcing the provision of nevirapine to all pregnant women in the public sector.
The Treatment Action Campaign had no reason to believe that the Medicines Control Council would withdraw the registration of the anti-retroviral drug nevirapine, the Pretoria High Court has heard.
Former President of South Africa, Nelson Mandela, went to Zola Clinic to inspect the Bill and Melinda Gates supported programme, where he announced that he would defend the Gauteng Premier's decision to provide pregnant mothers with nevirapine. Madiba was accompanied by Former US President Jimmy Carter and William Gates senior along with their wives.
SCIENTISTS and health professionals are squaring up to do battle with government and the African National Congress (ANC) on HIV/AIDS policy. This follows the release last week by the ANC's national executive committee (NEC) of a 10page document setting out its views on HIV/AIDS and signalling a retreat from what was seen as a tentative move towards liberalising policy on antiretroviral drugs.
The South African government has not yet decided whether to comply with the courts order to supply nevirapine to HIV positive pregnant mothers or to
appeal the order.
A report by a correspondent of Af-Aids Forum from the third African Development Forum in Addis Ababa, Maaaarch 3-8, 2002
"The HIV/AIDS pandemic is a survival issue not just for tens of millions of Africans, but also for some of our nations themselves... The HIV/AIDS pandemic will test those survival skills to the limit, but I have no doubt that Africa will overcome this pandemic, hopefully sooner rather than later." - Abdul Mohammed, Keynote Presentation.
Pages
3. Human Resources
Latest review reveals that voluntary community care can help and prevent SA losing R6bn a year to AIDS. IF SA began a massive home-based care programme for people infected with HIV/AIDS, it could slash hospital costs and relieve a fiscus already losing R6bn a year to AIDS. The losses are recorded in the latest intergovernmental review, while the cost benefits of using Home-Based Care are being proved by a two-year programme, Enhancing Care Initiative (ECI), run by the University of Natal, with the US's Harvard University and the KwaZulu-Natal government.
4. Public-Private Mix
Sara Bennett, Lucy Gilson
DFID Health Systems Resource Centre
UK Department for International Development, 2001
Health financing reforms are a core part of health sector development in low and middle income countries.The current focus of the international debate is on the need to move away from excessive reliance on out-of-pocket payment towards a system which incorporates a greater element of risk pooling (for example through health insurance) and thus affords a greater protection for the poor. This paper summarises what is known about the effects of the main health care financing systems, and how they can be designed and implemented to be 'pro-poor'.
5. Resource allocation and health financing
Adam Oliver, LSE Health and Social Care, London School of Economics and Political Science ISBN [07530 1932 9] Discussion Paper 2, February 2002. Health care resources are scarce, and there are competing moral claims on how the available resources ought to be distributed. Many of the claims focus upon the distribution of health outcomes, and thus assume that different health outcomes arising from disparate health care programmes can in some sense be compared. If cardinal values for health states could be elicited, they would help us to distribute resources more accurately towards our chosen health care objectives (whatever they might be).
Trudy Harpham, Emma Grant, South Bank University, London, UK and Elizabeth Thomas, Medical Research Council, Johannesburg, South Africa. Health Policy and Planning; 17(1): 106-111 Oxford University Press 2002. With growing recognition of the social determinants of health, social capital is an increasingly important concept in international health research. Although there is relatively little experience of measuring social capital, particularly in developing countries, there are now a number of studies that allow the identification of some key issues that need to be considered when measuring social capital.
Paolo Belli, Research Fellow, Department of Population and International Health Harvard School of Public Health - August 2001, Professor at Pavia University, Pavia Italy, and Lecturer at Bocconi University. This paper introduces a conceptual framework to investigate into the equity consequences of resource allocation, strategic purchasing and payment system reforms in health. It also presents a selective survey of the evidence available on the distribution of health, on utilization of public health services across socio-economic groups, and on the equity impact of RAP reforms in a number of developing countries.
6. Governance and participation in health
This desk review provides an update on practice and experiences of civil society participation in the development of Poverty Reduction Strategy Papers (PRSPs). It was commissioned by Department for International Development (DFID) and conducted from August–October 2001 by the Participation Group at the Institute of Development Studies (IDS) in the UK.
Deepa Narayan, Robert Chambers, Meera K. Shah and Patti Petesch - 2001
This book is based on the realities of poor people. It draws upon research conducted in 1999 involving 20,000 poor women and men from 23 countries. Despite very different political, social and economic contexts, there are striking similarities in poor people's experiences. The common theme underlying poor people's experiences is one of powerlessness. Powerlessness consists of multiple and interlocking dimensions of illbeing or poverty. The organisation of this book roughly follows the 10 dimensions of powerlessness and illbeing that emerge from the study. The remainder of the book presents methodology and the challenges faced in conducting the study.
7. Monitoring equity and research policy
This website has supported the high-level international seminar ‘Demanding Innovation: articulating policies for demand-led research and research capacity building in the South’ .
Under the Main Menu you will find basic information on the workshop, such as the programme, the names of the participants, keynote speeches, proceedings and background documents.
As researchers, we struggle constantly to ‘publish’, ‘disseminate’, ‘communicate’, or ‘influence’. We write short pieces which summarise our work. We organise and attend meetings. We give radio or television interviews. We offer evidence to parliamentary committees. Occasionally, we even answer the phone and find a decision-maker on the other end of the line. So much activity, for so uncertain an impact. And so little guidance on how to use our scarce resources. Surely, we can do better."
8. Useful Resources
Access to HIV/AIDS Drugs and Diagnostics of Acceptable Quality Pilot. Procurement Quality and Sourcing Project. Suppliers whose HIV-related medicines have been found acceptable, in principle, for procurement by UN agencies.
Gunther Eysenbach, senior researcher, Christian Köhler, researcher, Unit for Cybermedicine and eHealth, Department of Clinical Social Medicine, University of Heidelberg, Germany BMJ 2002;324:573-577 ( 9 March, 2002 ) Little is known about how consumers retrieve and assess health information on the world wide web. Some surveys have elicited data by using semistructured questionnaires or focus groups, but little (if any) unobtrusive observational research has been done to explore how consumers are actually surfing the web. Although several criteria for quality of health websites have been proposed, including disclosure of site owners, authors, and update cycle little or nothing is known about whether and to what degree such markers are recognised or even looked at by consumers or what other credibility markers consumers are looking for. The authors aimed to obtain qualitative and semiquantitative data to generate some hypotheses on how consumers might search for and appraise health information.
March, 2002. Women, Health and Development Program, Division of Health and Human Development (HDP), Pan-American Health Organization, PAHO/WHO Announces the launch of our new website devoted to Gender and Health issues. Join our listserv GENSALUD and have the latest Gender and Health news e-mailed to you. Download one of our Gender and Health Fact Sheets or Advocacy Kits. Browse through our Virtual Library on Gender and Health - SIMUS. Find a training course, seminar or workshop on gender and health. Visit our Education page for information about gender and women's studies programs throughout the Americas. Check out our Gender and Health Calendar to find out what's happening this month. Look for links to other organizations working on gender and women's health issues. Learn more about the Women, Health and Development Program!
With more than 115 programs profiled, this new, updated version responds to a growing interest in health services research and health policy and increasing demand for information about Post Baccalaureate certificates, Master's programs, Doctoral programs, and Postdoctoral programs in these fields. It has been expanded to include health policy research programs and the health policy tracks in public policy programs as well as the core health services research programs included in our two earlier editions-1997 and 1992. While the 2002 edition does not include international programs, other than the eight Canadian programs profiled, future editions may be expanded to include programs outside North America. Print copies will be available this spring. If Interested in profiling your program, please visit our website for detailed information. Contact Information: Virginia Van Horne,Academy for Health Services Research and Health Policy,1801 K Street, NW, Suite 701-L,Washington, DC 20006. Tel: 202-292-6744 Fax: 202-292-6844
20 March, 2002. The first issue of The Global Fund Update in the newsletter of the Global Fund to Fight AIDS, Tuberculosis and Malaria will provide the latest information about the progress of this historic initiative. The inaugural issue includes an introduction to the Global Fund and a brief update on plans to announce the first round of grants.
9. Jobs and Announcements
11-14 June 2002, International Convention Centre
Durban, South Africa.
We are pleased to invite you to attend the 14th Conference of the International Union Against Tuberculosis and Lung Disease (IUATLD) Africa Region to be held in Durban on 11-14 June 2002, in collaboration with the Department of Health of the Republic of South Africa. There is increased interest in tackling the tuberculosis, AIDS and tobacco epidemics in low income countries. WHO, NGOs and donor agencies are coordinating their efforts to reduce the burden affecting many low income countries by joining forces. Deadline for submission of abstracts: 20 April 2002. Early-bird registration: 10 May 2002.
3-4 June, 2002, Cape Town, South Africa.
The WHO-UNAIDS HIV Vaccine Initiative is organizing the First African AIDS Vaccine Programme (AAVP) Forum which is planned to be held at the Golden Tulip The Lord Charles Hotel, Cape Town, South Africa on 3-4 June 2002. The African AIDS Vaccine Programme (AAVP) is a network of scientists, working to promote and facilitate HIV vaccine research and evaluation in Africa, through capacity building and regional and international collaboration. The principal objective of this programme is to actively involve African scientists and communities in all stages of HIV vaccine development and evaluation.
Reporters will be able to explore a range of topics at the headquarters of the World Health Organization (WHO) in Geneva during a two week fellowship in October. An optional third week will be available to fellows to enable them to pursue their research in the field anywhere in the world. The WHO Journalism Fellowship is composed of two components to give reporters a broad and deep understanding of the forces shaping global public health. First, WHO Fellows will attend morning briefings on a range of international public health issues. The briefings will be held daily from 10 a.m. to noon. Then, during the remaining time, the fellows will have the freedom to roam WHO, to attend lectures and seminars, to interview staff, and to use WHO's extensive research resources to pursue their own special interests.
The World Bank's Thematic Group on Health, Nutrition and Population (HNP) and Poverty is pleased to invite applications for participation in a project designed to determine how well programs to improve Health, Nutrition and Population status are reaching disadvantaged population groups, and to find ways of reaching those groups more effectively. Financial support of up to $40,000 for each of 10-12 submissions, to be selected through open competition; the application deadline is April 19, 2002.
The Journal of Health,Population and Nutrition (JHPN) will publish theme-based issues, beginning in its March 2003 Issue to highlight findings of some important emergent research issues from different regions of the world. The first theme-based issue (March 2003) will be on Equity and Health.This special issue may include original research articles on concepts,measurements,and methodological issues, empirical findings on the situation of health equity,and interventions to reduce health inequity Reports on global evaluation,national,or subnational pro-equity activities and the experiences gained by way of impact and the process of implementation are also of interest. Potential authors are requested to express their interest to contribute by writing a note with tentative title of the paper by 30 June 2002.